3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
68
OTHER
56
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Breast Neoplasms
1
Interventions
Cyclophosphamide
42
Docetaxel
33
Paclitaxel
31
Tamoxifen
29
Doxorubicin
29
Trastuzumab
25
Radiotherapy
21
Epirubicin
16
Letrozole
15
Anastrozole
12
exemestane
11
Fluorouracil
11
Capecitabine
10
Bevacizumab
10
palbociclib
9
Immunohistochemistry
9
Fulvestrant
9
Filgrastim
9
Lapatinib
8
Zoledronic Acid
7
Methotrexate
7
Magnetic Resonance Spectroscopy
7
Gene Expression Profiling
7
pertuzumab
6
Triptorelin Pamoate
6
Taxes
6
Surgical Procedures, Operative
6
Microarray Analysis
6
Goserelin
6
Chemotherapy, Adjuvant
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
ribociclib
×
Breast
×
Clear all
NCT03283384
2025-09-19
NEOLBC
Borstkanker Onderzoek Groep
Phase 2
Active not recruiting
100 enrolled